Table 4 MVA of CSS
From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Parameter | p value | HR (95% CI) |
|---|---|---|
Age (≥ 50 vs. <  50 years) | 0.140 | 1.791 (0.826–3.883) |
Gender (male vs. female) | 0.822 | 1.092 (0.506–2.355) |
ECOG (3–4 vs 0–2) | 0.591 | 1.273 (0.527–3.075) |
Size (≥ 5 cm vs. <  5 cm) | 0.701 | 0.792 (0.241–2.603) |
OP method (non-gross total vs. gross total) | 0.627 | 0.831 (0.393–1.755) |
RT field (whole brain vs. small) | 0.382 | 1.449 (0.631–3.325) |
Galectin-1 (strong vs. weak) | 0.022 | 2.873 (1.163–7.101) |
Galectin-3 (strong vs. weak) | 0.993 | 1.004 (0.426–2.364) |